GSK Investigational Site

Parktown, Gauteng 2193

0 studies enrolling now · 10 studies all time

What they study most

Arthritis, Rheumatoid, Atherosclerosis, Diabetes Mellitus, Type 2, Herpes Zoster, Neoplasms, Breast, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A — Completed
• Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial — Completed
• A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects. — Completed
• Thiazolidinedione Intervention With Vitamin D Evaluation — Stopped early
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes — Completed
• Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes — Completed
• Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer — Completed